Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

NCT04891731 ·Status: UNKNOWN

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

NCT00329940 ·Status: COMPLETED ·Phase: PHASE3

Study of Breast Cancer Prevention by Letrozole in High Risk Women

NCT00579826 ·Status: COMPLETED ·Phase: PHASE2

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

NCT01122121 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

NCT00237133 ·Status: COMPLETED ·Phase: PHASE4

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

NCT01077453 ·Status: COMPLETED ·Phase: PHASE1

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

NCT00332852 ·Status: COMPLETED ·Phase: PHASE3

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

NCT00238316 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer

NCT00280930 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

NCT00330317 ·Status: COMPLETED ·Phase: PHASE3

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

NCT00673335 ·Status: COMPLETED ·Phase: PHASE3

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

NCT00171340 ·Status: COMPLETED ·Phase: PHASE3

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

NCT00171314 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

NCT06465368 ·Status: COMPLETED ·Phase: PHASE2

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

NCT00903162 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer

NCT00553410 ·Status: COMPLETED ·Phase: PHASE3

TRial on the Endocrine Activity of Neoadjuvant Degarelix

NCT02005887 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in Preventing Breast Cancer in Postmenopausal Women

NCT00090857 ·Status: COMPLETED ·Phase: PHASE2

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

NCT00535418 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Fertility Preservation in Breast Cancer Patients

NCT02661932 ·Status: COMPLETED ·Phase: PHASE4

Protocol for Women at Increased Risk of Developing Breast Cancer

NCT00291135 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

NCT00237224 ·Status: COMPLETED ·Phase: PHASE4

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

NCT02089854 ·Status: UNKNOWN ·Phase: PHASE4

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

NCT00080756 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2